Journal of Pineal Research · 1989 · 52 citations · 18 references
MedicineEndocrinologyPharmacologyCircadian RhythmsNeuropharmacologyPsychopharmacologyCircadian EndocrinologyGabaergic PharmacologySleep PhysiologyBenzodiazepine TreatmentMelatonin PharmacologyMelatonin PhysiologyMelatonin Secretion SuppressionMelatonin SuppressionMelatonin TreatmentPineal Gland FunctionRepeated Measures Anova
Several studies suggest that GABAergic mechanisms may be involved in the modulation of melatonin secretion. However, conflicting results have been reported in animal studies; in humans the issue has not been widely investigated. In the present study, using a double-blind design, six healthy men received orally, at midnight, 10 mg of diazepam, a GABAergic agent, or placebo, on two different occasions 1 week apart. Blood samples were collected, in the dark, immediately before the drug administration, and at 12:30, 1, 2, 3, and 4 AM. Serum melatonin was measured by a radioimmunological method with [125I]melatonin as a tracer. Two-way ANOVA with repeated measurements disclosed a significant effect for treatment (P less than 0.01), for time (P less than 0.0004), and for treatment X time interaction (P less than 0.05). Following diazepam administration, serum melatonin levels observed at 2, 3, and 4 AM were significantly lower than the corresponding values following placebo (P less than 0.002 at 2 and 4 AM; P less than 0.03 at 3 AM [Students' paired t test]). These results show that nocturnal blood melatonin levels may be suppressed by the acute administration of a GABAergic agent, suggesting that GABA may be involved in the modulation of pineal activity in man.
18
Ehud Ur · Postgraduate Medical Journal · 1991 · 345 citations · Full text
The mammalian pineal gland: Structure and function
Rüssel J. Reiter · American Journal of Anatomy · 1981 · 293 citations